Clinical Updates & Insights

Share

Our clinical updates provide you with timely information about Memorial Sloan Kettering’s new treatment approaches, key clinical trials, and innovations in detecting and treating many cancers.

193 Clinical Updates found
Cancer care patients maintaining physical activity
Overcoming Barriers to Maintaining Physical Activity during Cancer Care
Despite the proven benefits of exercise, even while receiving cancer treatment, new research undertaken by Memorial Sloan Kettering’s Integrative Medicine Service, shows that the majority of cancer patients report significant decreases in their physical activity levels after their cancer diagnosis.
Rehabilitation: A Crucial Factor in Care of Patients with Spinal Metastasis
Spinal metastasis is one of the main causes of morbidity in cancer patients, but despite recent studies showing the major benefits of rehabilitation in these cases, oncology teams often remain unclear on how and when to utilize these services.
Advanced Imaging in Diagnosis and Treatment of Biliary Cancer
Researchers in radiology at Memorial Sloan Kettering continue to assess multiple imaging methods in the quest to improve treatment options and success rates for patients with biliary cancers such as cholangiocarcinoma.
Pioneering New Treatments for Cholangiocarcinomas
Memorial Sloan Kettering is one of only a few centers in the U.S. to employ liver-directed therapies – using hepatic arterial infusion (HAI) – in conjunction with a number of systemic agents.
Novel Radiotherapy Technique Offers Hope for Patients with Liver and Pancreatic Tumors
Over the last decade radiation oncologists at Memorial Sloan Kettering have refined a technique that allows ablative doses of radiation to be delivered with low risk of toxicity to inoperable primary pancreas and liver tumors near critical organs.
Improving Melanoma Detection: Reflectance Confocal Microscopy
Advances in diagnostic and imaging modalities are making it possible to detect complex melanoma earlier, with greater accuracy, and are helping guide surgical approaches and patient monitoring plans.
Ipilimumab: Weighing the Benefits and Risks of Adjuvant Therapy for Melanoma
The decision as to whether to use high-dose iplimumab as an adjuvant treatment for melanoma is difficult and requires excellent communication between physician and patient.
The Psychological Challenges of Surviving Melanoma
Memorial Sloan Kettering’s Melanoma Disease Management Team understands the importance of helping these patients maximize the opportunities and overcome the challenges that arise in their lives.
Exciting New CAR T Cell Therapy Trial Opens at MSK
The effects of adoptive T cell therapy on mesothelioma and metastatic lung and breast cancers are the focus of a new Memorial Sloan Kettering Cancer Center trial, which, compared to some existing trials of therapy, offers some important differences for patients.
New Strides in Esophageal Cancer Management
Minimally invasive techniques, improved postoperative care, and a multidisciplinary approach help make Memorial Sloan Kettering Cancer Center’s rates of esophageal surgical morbidity and mortality among the country’s lowest.